A Stanford team has built soft, stretchable electronic skin that aims to restore...
Mpox has “a substantial risk of resurgence” health officials say, warning people...
U.S. Supreme Court has ruled against Amgen in a patent case that had the entire ...
A multibillion-dollar science agency tasked with slashing through research burea...
A federal appeals court panel heard arguments in a case that could determine the...
MTBVAC is the only live, attenuated mycobacterium TB vaccine in the pipeline.
The use of digital technology, such as apps, wearables and eConsent, has revolut...
The resubmitted NDA is based on a comprehensive development programme that inclu...
LPX-TI641 is being developed to treat neuro-autoimmune indications including mul...
The combined company will be named enGene Holdings on completion of the deal.
LMN-201 is given concomitantly with standard antibiotics and eight weeks thereaf...
Rivoceranib is an oral TKI, while camrelizumab is a PD-1 inhibitor.
Leaders must renew their commitment to eradicating NTDs if they are to achieve t...
Whilst medicine shortages are a global health problem, European countries are be...
The company aims to start the Phase II study of its lead compound zelquistinel i...
The Federal Trade Commission is widening its probe into PBMs and their impact on...
